BioCentury
ARTICLE | Clinical News

Telapristone: Phase IIb started

January 26, 2015 8:00 AM UTC

Repros began a double-blind, placebo-controlled Phase IIb trial to evaluate 6 and 12 mg oral Proellex in 18-week courses for up to 2 courses in about 45 premenopausal woman. The courses will be separa...